Insights into the glycosaminoglycan-mediated cytotoxic mechanism of eosinophil cationic protein revealed by NMR

ACS Chemical Biology

Volumn 8, Issue 1, 2013, Pages 144-151

  García Mayoral, M Flor ^a   Canales, Ángeles ^b   Díaz, Dolores ^c   López Prados, Javier ^d   Moussaoui, Mohammed ^e   De Paz, José L ^d   Angulo, Jesús ^d   Nieto, Pedro M ^d   Jiménez Barbero, Jesús ^c   Boix, Ester ^e   Bruix, Marta ^a  

^a INSTITUTO DE QUÍMICA FÍSICA ROCASOLANO   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^d INSTITUTO DE INVESTIGACIONES QUÍMICAS   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; GLYCOSAMINOGLYCAN; HEPARIN;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL MEMBRANE; CYTOTOXICITY; EOSINOPHIL; MAMMAL CELL; MOLECULAR DYNAMICS; MOLECULAR MODEL; MOLECULAR RECOGNITION; NITROGEN NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN CONFORMATION; PROTEIN TERTIARY STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE;

BINDING SITES; CELL MEMBRANE; CYTOTOXINS; EOSINOPHIL CATIONIC PROTEIN; GLYCOSAMINOGLYCANS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR DYNAMICS SIMULATION; PROTEIN FOLDING;

EID: 84872582583     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb300386v     Document Type: Article

References (58)

1. Ardelt, W., Ardelt, B., and Darzynkiewicz, Z. (2009) Ribonucleases as potential modalities in anticancer therapy Eur. J. Pharmacol. 625, 181-189
2. Rosenberg, H. F. (2008) RNase A ribonucleases and host defense: an evolving story J. Leukocyte Biol. 83, 1079-1087 (Pubitemid 351960339)
3. Sorrentino, S. (2010) The eight human "canonical" ribonucleases: molecular diversity, catalytic properties, and special biological actions of the enzyme proteins FEBS Lett. 584, 2194-2200
4. Boix, E., Salazar, V. A., Torrent, M., Pulido, D., Nogués, M. V., and Moussaoui, M. (2012) Structural determinants of the eosinophil cationic protein antimicrobial activity Biol. Chem. 393, 801-815
5. Malik, A. and Batra, J. K. (2012) Antimicrobial activity of human eosinophil granule proteins: involvement in host defence against pathogens Crit. Rev. Microbiol. 38, 168-181
6. Bystrom, J., Amin, K., and Bishop-Bailey, D. (2011) Analysing the eosinophil cationic protein-a clue to the function of the eosinophil granulocyte Respir. Res. 12, 10
7. Gupta, S. K., Haigh, B. J., Griffin, F. J., and Wheeler, T. T. (2012) The mammalian secreted RNases: Mechanisms of action in host defence Innate Immun. 10.1177/1753425912446955
8. Hogan, S. P., Rosenberg, H. F., Moqbel, R., Phipps, S., Foster, P. S., Lacy, P., Kay, A. B., and Rothenberg, M. E. (2008) Eosinophils: Biological properties and role in health and disease Clin. Exp. Allergy 38, 709-750 (Pubitemid 351550670)
9. Navarro, S., Boix, E., Cuchillo, C. M., and Nogués, M. V. (2010) Eosinophil-induced neurotoxicity: The role of eosinophil cationic protein/RNase 3 J. Neuroimmunol. 227, 60-70
10. Domachowske, J. B., Dyer, K. D., Adams, A. G., Leto, T. L., and Rosenberg, H. F. (1998) Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity Nucleic Acid Res. 24, 3507-3513
11. Rosenberg, H. F. (1995) Recombinant human eosinophil cationic protein. Ribonuclease activity is not essential for cytotoxicity J. Biol. Chem. 270, 7876-7881
12. Motojima, S., Frigas, E., Loegering, D. A., and Gleich, G. J. (1989) Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro Am. Rev. Respir. Dis. 139, 801-805 (Pubitemid 19084409)
13. Hohlfeld, J. M., Schmiedl, A., Erpenbeck, V. J., Venge, P., and Krug, N. (2004) Eosinophil cationic protein alters pulmonary surfactant structure and function in asthma J. Allergy Clin. Immunol. 113, 496-502 (Pubitemid 38338956)
14. Maeda, T., Kitazoe, M., Tada, H., de Llorens, R., Salomom, D. S., Ueda, M., Yamada, H., and Seno, M. (2002) Growth inhibition of mammalian cells by eosinophil cationic protein Eur. J. Biochem. 269, 306-316
15. Carreras, E., Boix, E., Navarro, S., Rosenberg, H. F., Cuchillo, C. M., and Nogués, M. V. (2005) Surface-exposed amino acids of eosinophil cationic protein play a critical role in the inhibition of mammalian cell proliferation Mol. Cell. Biochem. 272, 1-7 (Pubitemid 40867359)
16. Navarro, S., Aleu, J., Jiménez, M., Boix, E., Cuchillo, C. M., and Nogués, M. V. (2008) The cytotoxicity of eosinophil cationic protein/ribonuclease 3 on eukaryotic cell lines takes place through its aggregation on the cell membrane Cell. Mol. Life Sci. 65, 324-337
17. Jacobsen, E. A., Helmers, R. A., Lee, J. J., and Lee, N. A. The expanding role(s) of eosinophils in health and disease. Blood 2012, in press.
18. Wechsler, M. E., Fulkerson, P. C., Bochner, B. S., Gauvreau, G. M., Gleich, G. J., Henkel, T., Kolbeck, R., Mathur, S. K., Ortega, H., Patel, J., Prussin, C., Renzi, P., Rothenberg, M. E., Roufosse, F., Simon, D., Simon, H. U., Wardlaw, A., Weller, P. F., and Klion, A. D. (2012) Novel targeted therapies for eosinophilic disorders J. Allergy Clin. Immuno. 130, 563-571
19. Ahmed, T., Smith, G., Vlahov, I., and Abraham, W. M. (2012) Inhibition of allergic airway responses by heparin derived oligosaccharides: identification of a tetrasaccharide sequence Respir. Res. 13, 6
20. Fan, T. C., Chang, H. T., Chen, I. W., Wang, H. Y., and Chang, M. D. T. (2007) A heparan sulfate-facilitated and raft-dependent macropinocytosis of eosinophil cationic protein Traffic 8, 1778-1795
21. Fuchs, S. M. and Raines, R. T. (2006) Internalization of cationic peptides: the road less (or more?) traveled Cell. Mol. Life Sci. 63, 1819-1822
22. Chao, T. Y., Lavis, L. D., and Raines, R. T. (2010) Cellular uptake of ribonuclease A relies on anionic glycans Biochemistry 49, 10666-10673
23. Laurents, D. V., Bruix, M., Jiménez, M. A., Santoro, J., Boix, E., Moussaoui, M., Nogués, M. V., and Rico, M. (2009) The 1H, 13C, 15N resonance assignment, solution structure, and residue level stability of eosinophil cationic protein/RNase 3 determined by NMR spectroscopy Biopolymers 91, 1018-1028
24. Boix, E., Leonidas, D. D., Nikolovski, Z., Nogués, M. V., and Cuchillo, C. M. (1999) Crystal structure of eosinopkil cationic protein at 2.4 Ǻ resolution Biochemistry 38, 16794-16801
25. Mallorquí-Fernández, G., Pous, J., Peracaula, R., Aymani, J., Maeda, T., Tada, H., Yamada, H., Seno, M., de Llorens, R., Gomis-Rüth, F. X., and Coll, M. (2000) Three-dimensional crystal structure of human eosinophil cationic protein (RNase 3) at 1.75 Ǻ resolution J. Mol. Biol. 300, 1297-1307
26. Boix, E., Pulido, D., Moussaoui, M., Nogués, M. V., and Russi, S. (2012) The sulfate-binding site structure of the human eosinophil cationic protein as revealed by a new crystallographic form J. Struct. Biol. 179, 1-9
27. Mohan, C. G., Boix, E., Evans, H. R., Nikolovski, Z., Nogués, M. V., Cuchillo, C. M., and Acharya, K. R. (2002) The crystal structure of eosinophil cationic protein in complex with 2′,5′-ADP at 2.0 Ǻ resolution reveals the details of the ribonucleolytic active site Biochemistry 41, 12100-12106
28. Canales, A., Lozano, R., López-Méndez, B., Angulo, J., Ojeda, R., Nieto, P. M., Martín-Lomas, M., Giménez-Gallego, G., and Jiménez-Barbero, J. (2006) Solution NMR structure of a human FGF-1 monomer, activated by a hexasaccharide heparin-analogue FEBS J. 273, 4716-4727 (Pubitemid 44506911)
29. Bishop, J. R., Schuksz, M., and Esko, J. D. (2007) Heparan sulphate proteoglycans fine-tune mammalian physiology Nature 446, 1030-1037 (Pubitemid 46676065)
30. Gandhi, N. S. and Mancera, R. L. (2010) Heparin/heparan sulphate-based drugs Drug Discovery Today 15, 1058-1069
31. Fan, T. C., Fang, S. L., Hwang, C. S., Hsu, C. Y., Lu, X. A., Hung, S. C., Lin, S. C., and Chang, M. D. T. (2008) Characterization of molecular interactions between eosinophil cationic protein and heparin J. Biol. Chem. 283, 25468-25474
32. García-Mayoral, M. F., Moussaoui, M., de la Torre, B. G., Andreu, D., Boix, E., Nogués, M. V., Rico, M., Laurents, D. V., and Bruix, M. (2010) NMR structural determinants of eosinophil cationic protein binding to membrane and heparin mimetics Biophys. J. 98, 2702-2711
33. Skinner, R., Abrahams, J. P., Whisstock, J. C., Lesk, A. M., Carrell, R. W., and Wardell, M. R. (1997) The 2.6 Ǻ structure of antithrombin indicates a conformational change at the heparin binding site J. Mol. Biol. 266, 601-609 (Pubitemid 27117291)
34. Angulo, J., Nieto, P. M., and Martín-Lomas, M. (2003) A molecular dynamics description of the conformational flexibility of the L-iduronate ring in glycosaminoglycans Chem. Commun. 13, 1512-1513 (Pubitemid 36782872)
35. Mulloy, B., Forster, M. J., Jones, C., and Davies, D. B. (1993) N.m.r. and molecular-modelling studies of the solution conformation of heparin Biochem. J. 293, 849-858 (Pubitemid 23244575)
36. Mulloy, B. and Forster, M. J. (2000) Conformation and dynamics of heparin and heparan sulfate Glycobiology 10, 1147-1156
37. Sue, S. C., Brisson, J. R., Chang, S. C., Huang, W. N., Lee, S. C., Jarrell, H. C., and Wu, W. (2001) Structures of heparin-derived disaccharide bound to cobra cardiotoxins: context-dependent conformational change of heparin upon binding to the rigid core of the three-fingered toxin Biochemistry 40, 10436-10446 (Pubitemid 32816654)
38. Faham, S., Hileman, R. E., Fromm, J. R., Linhardt, R. J., and Rees, D. C. (1996) Heparin structure and interactions with basic fibroblast growth factor Science 271, 1116-1120 (Pubitemid 26075225)
39. Tjong, S. C., Chen, T. S., Huang, W. N., and Wu, W. (2007) Structures of heparin-derived tetrasaccharide bound to cobra cardiotoxins: heparin binding at a single protein site with diverse side chain interactions Biochemistry 46, 9941-9952 (Pubitemid 47378584)
40. Torrent, M., Nogués, M. V., and Boix, E. (2011) Eosinophil cationic protein (ECP) can bind heparin and other glycosaminoglycans through its RNase active site J. Mol. Recognit. 24, 90-100
41. M heparin pentasaccharide when bound to the fibroblast growth factor receptor Chemistry 17, 11204-11209
42. Pineda-Lucena, A., Jiménez, M. A., Nieto, J. L., Santoro, J., Rico, M., and Giménez-Gallego, G. (1994) 1H-NMR assignment and solution structure of human acidic fibroblast growth factor activated by inositol hexasulfate J. Mol. Biol. 242, 81-98
43. Swaminathan, G. J., Myszka, D. G., Katsamba, P. S., Ohnuki, L. E., Gleich, G. J., and Acharya, K. R. (2005) Eosinophil-granule major basic protein, a C-type lectin, binds heparin Biochemistry 44, 14152-14158 (Pubitemid 41533040)
44. Xue, Y., Lee, S., and Ha, Y. (2011) Crystal structure of amyloid precursor-like protein 1 and heparin complex suggests a dual role of heparin in E2 dimerization Proc. Natl. Acad. Sci. U.S.A. 108, 16229-16234
45. Asensio, J. L., Ardá, A., Cañada, F. J., and Jiménez-Barbero, J. (2012) Carbohydrate-aromatic interactions Acc. Chem. Res. 10.1021/ar300024d
46. Mikhailov, D., Linhardt, R. J., and Mayo, K. H. (1997) NMR solution conformation of heparin-derived hexasaccharide Biochem. J. 328, 51-61 (Pubitemid 27499439)
47. Carreras, E., Boix, E., Rosenberg, H. F., Cuchillo, C. M., and Nogués, M. V. (2003) Both aromatic and cationic residues contribute to the membrane-lytic and bactericidal activity of eosinophil cationic protein Biochemistry 42, 6636-6644 (Pubitemid 36666104)
48. Torrent, M., Cuyas, E., Carreras, E., Navarro, S., López, O., de la Maza, A., Nogués, M. V., Reshetnyak, Y. K., and Boix, E. (2007) Topography studies on the membrane interaction mechanism of the eosinophil cationic protein Biochemistry 46, 720-733 (Pubitemid 46133588)
49. Lehrer, R. I., Szklarek, D., Barton, A., Ganz, T., Hamann, K. J., and Gleich, G. J. (1989) Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein J. Immunol. 142, 4428-4434 (Pubitemid 19162336)
50. Torrent, M., Badia, M., Moussaoui, M., Sánchez, D., and Nogués, M. V. (2010) Comparison of human RNase 3 and RNase 7 bactericidal action at the Gram-positive bacterial cell wall FEBS J. 277, 1713-1725
51. Sue, S. C., Chien, K. Y., Huang, W. N., Abraham, J. K., Chen, K. M., and Wu, W. (2002) Heparin binding stabilizes the membrane-bound form of cobra cardiotoxin J. Biol. Chem. 227, 2666-2673 (Pubitemid 34953293)
52. Capila, I., Hernáiz, M. J., Mo, Y. D., Mealy, T. R., Campos, B., Dedman, J. R., Linhardt, R. J., and Seaton, B. A. (2001) Annexin V-heparin oligosaccharide complex suggests heparan sulfate-mediated assembly on cell surfaces Structure 9, 57-64 (Pubitemid 32064350)
53. Kuschert, G. S., Coulin, F., Power, C. A., Proudfoot, A. E., Hubbard, R. E., Hoogewerf, A. J., and Wells, T. N. (1999) Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses Biochemistry 37, 11193-11201
54. Murphy, J. W., Cho, Y., Sachpatzidis, A., Fan, C., Hodsdon, M. E., and Lolis, E. (2007) Structural and functional basis of CXCL12 (stromal cell-derived factor-1a) binding to heparin J. Biol. Chem. 282, 10018-10027 (Pubitemid 47104591)
55. Evans, D. L., Marshall, C. J., Christey, P. B., and Carrell, R. W. (1992) Heparin binding site, conformational change, and activation of antithrombin Biochemistry 31, 12629-12642 (Pubitemid 23016530)
56. de Paz, J. L., Angulo, J., Lassaletta, J. M., Nieto, P. M., Redondo-Horcajo, M., Lozano, R. M., Giménez-Gallego, G., and Martín-Lomas, M. (2001) The activation of fibroblast growth factors by heparin: synthesis, structure, and biological activity of heparin-like oligosaccharides ChemBioChem 2, 673-685 (Pubitemid 33722619)
57. Muñoz-García, J. C., López-Prados, J., Angulo, J., Díaz-Contreras, I., Reichardt, N. C., de Paz, J. L., Martín-Lomas, M., and Nieto, P. M. (2012) Effect of the substituents of neighbour ring in the conformational equilibrium of iduronate in heparin-like trisaccharides Chemistry 10.1002/chem.201202770
58. Boix, E., Nikolovski, Z., Moiseyev, G. P., Rosenberg, H. F., Cuchillo, C. M., and Nogués, M. V. (1999) Kinetic and product distribution analysis of human eosinophil cationic protein indicates a subsite arrangement that favors exonuclease-type activity J. Biol. Chem. 274, 15605-15614